DGX affiliate files Form 144 to sell 10,000 shares

DGX affiliate submitted a Form 144 notice to sell 10,000 shares.

Rhea-AI Filing Summary

DGX affiliate submitted a Form 144 notice to sell 10,000 shares. The excerpt shows a reported sale of 10,000 common shares on 03/02/2026 for $2,125,200.00. The filing lists prior restricted stock vesting events of 1,164, 7,232, and 1,604 shares on 02/17/2022, 02/18/2022, and 02/24/2023. Shares outstanding are shown as 110,696,429 as of 06/01/2026.

Insights

Securities Counsel

Notice of proposed sale by an affiliate; sale amount and dates are disclosed.

The filing lists a proposed or reported sale of $2,125,200.00 for 10,000 common shares on 03/02/2026. It also enumerates restricted stock vesting events and a shares‑outstanding figure as of 06/01/2026.

Cash‑flow treatment and whether sales were brokered or private are not stated in the excerpt; subsequent SEC filings or broker confirmations would provide execution details and settlement mechanics.

Key Figures

Shares sold: 10,000 shares Proceeds: $2,125,200.00 Shares outstanding: 110,696,429 shares +3 more

6 metrics

Shares sold 10,000 shares sale reported on 03/02/2026

Proceeds $2,125,200.00 amount shown for 10,000 shares on 03/02/2026

Shares outstanding 110,696,429 shares as of 06/01/2026

Restricted stock vesting 1,164 shares vested 02/17/2022

Restricted stock vesting 7,232 shares vested 02/18/2022

Restricted stock vesting 1,604 shares vested 02/24/2023

Key Terms

Form 144, Restricted Stock Vesting, Issuer

3 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Restricted Stock Vesting | Issuer | 02/17/2022"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Issuer regulatory

"Restricted Stock Vesting | Issuer | 02/18/2022"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the DGX Form 144 show about the sale?

The Form 144 shows a reported sale of 10,000 common shares on 03/02/2026 with proceeds of $2,125,200.00. It lists vesting events and an outstanding share count as context in the excerpt.

Who is the reported seller on the DGX excerpt?

The excerpt names James E. Davis with an address in Secaucus, NJ, as the filer for the 10,000‑share sale on 03/02/2026. The filing identifies the seller and sale date in the provided lines.

Does the filing list other securities or vesting events for DGX?

Yes. The excerpt lists restricted stock vesting entries of 1,164, 7,232, and 1,604 common shares on 02/17/2022, 02/18/2022, and 02/24/2023, respectively, labeled as compensation.

What shares‑outstanding figure is included in the excerpt for DGX?

The excerpt shows 110,696,429 shares outstanding as of 06/01/2026. This number appears on the filer information line in the provided content.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/01/2026 - 12:26 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001599837
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	QUEST DIAGNOSTICS INC
SEC File Number	001-12215
Address of Issuer	500 PLAZA DRIVE SECAUCUS NEW JERSEY 07094
Phone	9735202700
Name of Person for Whose Account the Securities are To Be Sold	Davis J. E.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10000	1941360.00	110696429	06/01/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2022	Restricted Stock Vesting	Issuer			1164	02/17/2022	Compensation
Common	02/18/2022	Restricted Stock Vesting	Issuer			7232	02/18/2022	Compensation
Common	02/24/2023	Restricted Stock Vesting	Issuer			1604	02/24/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James E. Davis 500 Plaza Drive Secaucus NY 07094	Common	03/02/2026	10000	2125200.00

144: Remarks and Signature

Remarks
Date of Notice	06/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/26/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for James Davis
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)